234 related articles for article (PubMed ID: 10591056)
1. MAO-A and -B gene knock-out mice exhibit distinctly different behavior.
Shih JC; Chen K
Neurobiology (Bp); 1999; 7(2):235-46. PubMed ID: 10591056
[TBL] [Abstract][Full Text] [Related]
2. Role of MAO A and B in neurotransmitter metabolism and behavior.
Shih JC; Chen K; Ridd MJ
Pol J Pharmacol; 1999; 51(1):25-9. PubMed ID: 10389141
[TBL] [Abstract][Full Text] [Related]
3. Cloning, after cloning, knock-out mice, and physiological functions of MAO A and B.
Shih JC
Neurotoxicology; 2004 Jan; 25(1-2):21-30. PubMed ID: 14697877
[TBL] [Abstract][Full Text] [Related]
4. Monoamine oxidase: from genes to behavior.
Shih JC; Chen K; Ridd MJ
Annu Rev Neurosci; 1999; 22():197-217. PubMed ID: 10202537
[TBL] [Abstract][Full Text] [Related]
5. Novel multifunctional neuroprotective iron chelator-monoamine oxidase inhibitor drugs for neurodegenerative diseases. In vivo selective brain monoamine oxidase inhibition and prevention of MPTP-induced striatal dopamine depletion.
Gal S; Zheng H; Fridkin M; Youdim MB
J Neurochem; 2005 Oct; 95(1):79-88. PubMed ID: 16181414
[TBL] [Abstract][Full Text] [Related]
6. Progress in monoamine oxidase (MAO) research in relation to genetic engineering.
Nagatsu T
Neurotoxicology; 2004 Jan; 25(1-2):11-20. PubMed ID: 14697876
[TBL] [Abstract][Full Text] [Related]
7. Increased stress response and beta-phenylethylamine in MAOB-deficient mice.
Grimsby J; Toth M; Chen K; Kumazawa T; Klaidman L; Adams JD; Karoum F; Gal J; Shih JC
Nat Genet; 1997 Oct; 17(2):206-10. PubMed ID: 9326944
[TBL] [Abstract][Full Text] [Related]
8. Localization of MAO-A and MAO-B in human brain: a step in understanding the therapeutic action of L-deprenyl.
Riederer P; Konradi C; Schay V; Kienzl E; Birkmayer G; Danielczyk W; Sofic E; Youdim MB
Adv Neurol; 1987; 45():111-8. PubMed ID: 3030067
[TBL] [Abstract][Full Text] [Related]
9. Biochemical effects of the monoamine neurotoxins DSP-4 and MDMA in specific brain regions of MAO-B-deficient mice.
Fornai F; Giorgi FS; Gesi M; Chen K; Alessrì MG; Shih JC
Synapse; 2001 Mar; 39(3):213-21. PubMed ID: 11169770
[TBL] [Abstract][Full Text] [Related]
10. MAO-B knockout mice exhibit deficient habituation of locomotor activity but normal nicotine intake.
Lee M; Chen K; Shih JC; Hiroi N
Genes Brain Behav; 2004 Aug; 3(4):216-27. PubMed ID: 15248867
[TBL] [Abstract][Full Text] [Related]
11. [Discovery of monoamine oxidase forms A and B].
Squires RF
Vopr Med Khim; 1997; 43(6):433-9. PubMed ID: 9503561
[TBL] [Abstract][Full Text] [Related]
12. From genes to aggressive behavior: the role of serotonergic system.
Popova NK
Bioessays; 2006 May; 28(5):495-503. PubMed ID: 16615082
[TBL] [Abstract][Full Text] [Related]
13. Early postnatal inhibition of serotonin synthesis results in long-term reductions of perseverative behaviors, but not aggression, in MAO A-deficient mice.
Bortolato M; Godar SC; Tambaro S; Li FG; Devoto P; Coba MP; Chen K; Shih JC
Neuropharmacology; 2013 Dec; 75():223-32. PubMed ID: 23871843
[TBL] [Abstract][Full Text] [Related]
14. [Inhibitory effects of the extract of pilose antler on monoamine oxidase in aged mice].
Chen X; Jia Y; Wang B
Zhongguo Zhong Yao Za Zhi; 1992 Feb; 17(2):107-10, 128. PubMed ID: 1418524
[TBL] [Abstract][Full Text] [Related]
15. Distinct structure and activity of monoamine oxidase in the brain of zebrafish (Danio rerio).
Anichtchik O; Sallinen V; Peitsaro N; Panula P
J Comp Neurol; 2006 Oct; 498(5):593-610. PubMed ID: 16917825
[TBL] [Abstract][Full Text] [Related]
16. CSC, an adenosine A(2A) receptor antagonist and MAO B inhibitor, reverses behavior, monoamine neurotransmission, and amino acid alterations in the 6-OHDA-lesioned rats.
Aguiar LM; Macêdo DS; Vasconcelos SM; Oliveira AA; de Sousa FC; Viana GS
Brain Res; 2008 Jan; 1191():192-9. PubMed ID: 18164694
[TBL] [Abstract][Full Text] [Related]
17. Discovery of a novel class of potent coumarin monoamine oxidase B inhibitors: development and biopharmacological profiling of 7-[(3-chlorobenzyl)oxy]-4-[(methylamino)methyl]-2H-chromen-2-one methanesulfonate (NW-1772) as a highly potent, selective, reversible, and orally active monoamine oxidase B inhibitor.
Pisani L; Muncipinto G; Miscioscia TF; Nicolotti O; Leonetti F; Catto M; Caccia C; Salvati P; Soto-Otero R; Mendez-Alvarez E; Passeleu C; Carotti A
J Med Chem; 2009 Nov; 52(21):6685-706. PubMed ID: 19810674
[TBL] [Abstract][Full Text] [Related]
18. Cloning of a novel monoamine oxidase cDNA from trout liver.
Chen K; Wu HF; Grimsby J; Shih JC
Mol Pharmacol; 1994 Dec; 46(6):1226-33. PubMed ID: 7808446
[TBL] [Abstract][Full Text] [Related]
19. Types A and B monoamine oxidase contribute to the metabolism of norepinephrine in perfused lungs of rats.
Westwood NN; Bryan-Lluka LJ
J Pharmacol Exp Ther; 1993 Nov; 267(2):815-21. PubMed ID: 8246156
[TBL] [Abstract][Full Text] [Related]
20. Elucidating the mechanism of action and potential interactions of MAO-B inhibitors.
Bainbridge JL; Page RL; Ruscin JM
Neurol Clin; 2008 Aug; 26(3 Suppl):S85-96, vi. PubMed ID: 18774444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
